Zuellig's Korean style business conduct to criticize

Published: 2000-11-23 10:44:00

Updated: 2000-11-23 10:44:00

The pharmaceutical business circle recently criticized Zuellig Korea that they committed slightly unreasonable business practices with their associated wholesalers in defiance of the motto they earlier proclaimed at the time of their business entry into Korea, as saying that they introduce the mo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK